Status:
RECRUITING
A PRPCT to Assess the Efficacy & Safety of Chronic Pain Rehab Training Software for Alleviating Chronic Secondary Musculoskeletal Pain
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A prospective, randomized, parallel-controlled clinical trial to evaluate the effectiveness and safety of chronic pain rehabilitation training software in assisting in the relief of chronic secondary ...
Detailed Description
A PRPCT to assess the efficacy \& safety of chronic pain rehab training software for alleviating chronic secondary musculoskeletal pain
Eligibility Criteria
Inclusion
- Males and females ≥18 years old.
- Average pain intensity≥4 on a 0-10 numerical rating scale (NRS) in the past 24 hours.
- Be able to communicate in Chinese.
- Be able to read and write Chinese.
- Willing to comply with study procedures and restrictions.
- Willing and able to sign informed consent.
Exclusion
- Shingles on the eyes, ears, head, face, or hands.
- Trigeminal neuralgia.
- Severe vision impairment. (Patients with clear vision wearing glasses or contact lenses are allowed)
- Severe hearing impairment.
- Disease or medical condition predisposing to nausea or dizziness, such as insufficient blood supply to the brain, vestibular dysfunction,cholecystitis, etc.
- History of severe motion sickness.
- Injury to eyes, ears, face, or neck that impedes comfortable use of mixed reality.
- Injury or dysfunction of hands or upper limbs that impedes comfortable use of mixed reality.
- Diagnosis of cognitive impairment, epilepsy, dementia, migraines or other neurological diseases that may prevent the use of mixed reality.
- History of mental illness, including depression, generalized anxiety disorder, schizophrenia, etc.
- Females currently pregnant.
- Current or completion of participation within 4 weeks before screening in any interventional clinical study
- Patients whom the investigator considers not suitable to participate in this study.
Key Trial Info
Start Date :
November 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 12 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06936059
Start Date
November 12 2025
End Date
November 12 2026
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinhua hospital ,Shanghai Jiaotong University, School of medicine
Shanghai, Shanghai Municipality, China, 20000